Enabling Innovative Drug Discovery with Advanced Technologies
HitGen provides one-stop small molecule drug discovery for innovative drug programs, taking full advantage of the integration of target nomination, protein engineering, expression and purification, DEL screening powered novel hit identification, medicinal chemistry optimization, in vitro biophysical and biochemical assays, cellular assays, in vitro and in vivo pharmacology, pharmacokinetics, toxicology, CMC, formulation, quality control, IND enabling studies and etc.
We use cookies to provide a better web experience.
By using our site, you acknowledge our use of cookies and please read our Cookie Notice for
More information